(“CSPC”) (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrough therapy designation by the Center for Drug ...
Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT (fluorouracil, leucovorin, ...
Dr Anjali Pathak discusses four cases of skin cancer or pre-cancer - involving potentially malignant skin lesions - and their management ...
Aranscia® solutions help oncologists comply with new FDA warning label requiring  DPYD genetic testing in patients receiving select chemotherapies HOUSTON , Oct.
Durvalumab is currently approved for a number of cancer types. Though not approved in gastric cancer, the MATTERHORN regimen is currently under review by the FDA for the perioperative setting, with a ...
The HERCULES trial shows pembrolizumab plus chemotherapy produces a 39.4% response rate in advanced penile cancer, offering new treatment hope globally.
NUC-3373 Plus Pembrolizumab Continues to Show Favorable Efficacy and Safety Profile in Heavily Pre-treated Patients Latest Data Cut-Off Shows Patient with Melanoma Remains Progression-Free at 23 Month ...
Former President Joe Biden will begin radiation therapy and hormone treatment for prostate cancer, according to a statement from his spokesperson. He was diagnosed with an "aggressive" form of ...
Colorado and over 20 other states have banned the practice aimed at changing the sexual orientation or gender identity of young people. Ann E. Marimow Reporting from Washington A central question for ...
The Supreme Court appeared receptive to a landmark challenge to a Colorado law banning "conversion therapy" for children questioning their sexuality or gender identity. More than half the states have ...
Washington — The Supreme Court is set to convene Tuesday to consider a legal battle involving a Colorado law banning "conversion therapy" treatment for minors brought by a licensed counselor in the ...